Advancements in CRISPR-Cas9 for Genetic Disorders

Authors

  • Samuel Stewart PhD
  • Kai Harris Dr.
  • Avery Hernandez Prof.

Keywords:

CRISPR-Cas9, genetic disorders, gene editing, cystic fibrosis, muscular dystrophy

Abstract

This article reviews the latest advancements in CRISPR-Cas9 technology for the treatment of genetic disorders. We assess its application in gene editing for conditions like cystic fibrosis and muscular dystrophy. The precision and efficiency of CRISPR-Cas9 have revolutionized the field, offering potential cures for previously untreatable diseases. Despite ethical concerns and technical challenges, ongoing research continues to advance its clinical applications. This review provides insights into current breakthroughs and future directions for CRISPR-Cas9 in medical science.

Author Biographies

Samuel Stewart, PhD

PhD
University of Cambridge
The Old Schools, Trinity Ln, Cambridge CB2 1TN, United Kingdom

Kai Harris, Dr.

Dr.
University of Sydney
Camperdown NSW 2006, Australia

Avery Hernandez, Prof.

Prof.
University of Tokyo
7 Chome-3-1 Hongo, Bunkyo City, Tokyo 113-8654, Japan

References

Сабри, М. (2022). Cervical Cancer Prevention: Awareness Assessment Research of Healthy and Disease-Affected Women / Профилактика на рака на маточната шийка: оценка на информираността при здрави и болни жени (Doctoral dissertation). Medical University of Varna. [Sabri, M. (2022). Cervical Cancer Prevention: Awareness Assessment Research of Healthy and Disease-Affected Women / Profilaktika na raka na matochnata shiyka: otsenka na informiranostta pri zdravi i bolni zheni (Doctoral dissertation). Medical University of Varna]. Available at: https://repository.mu-varna.bg/handle/nls/2725

Sabri, M. (2021, August). Prophylactic Examinations For Cervical Cancer–Mandatory Precaution That Can Save A Life. In Varna Medical Forum (Vol. 10, No. 2, pp. 443-448).

Published

2026-02-26

Issue

Section

Articles